Vistas y estadísticas descargadas: Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC
Mapa geográfico
| Región | # |
|---|---|
| NA - América del Norte | 70 |
| AS - Asia, otros | 16 |
| EU - Europa | 13 |
| SA - América del Sur | 5 |
| Total | 104 |
| País | # |
|---|---|
| US - Estados Unidos de América | 69 |
| CN - China | 8 |
| SG - Singapur | 7 |
| IE - Irlanda | 4 |
| RU - Federación Rusa | 3 |
| BR - Brasil | 2 |
| ES - España | 2 |
| PE - Perú | 2 |
| TR - Turquía | 2 |
| AR - Argentina | 1 |
| other - Otro País | 4 |
| Total | 104 |
| Ciudad | Cantidad |
|---|---|
| Chandler | 7 |
| Chicago | 6 |
| Ashburn | 4 |
| Dublin | 4 |
| Shanghai | 4 |
| Ankara | 2 |
| Phoenix | 2 |
| Singapore | 2 |
| Barcelona | 1 |
| Council Bluffs | 1 |
| other | 71 |
| Total | 104 |
| Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 4 |
| 2022 | 6 | 1 | 0 | 0 | 1 | 0 | 4 | 2 | 0 | 8 | 2 | 6 | 30 |
| 2023 | 0 | 0 | 3 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 3 | 1 | 11 |
| 2024 | 3 | 0 | 3 | 7 | 6 | 2 | 2 | 2 | 8 | 7 | 5 | 1 | 46 |
| 2025 | 3 | 8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 |
| TOTAL | 104 | ||||||||||||